pubmed-article:8374502 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:8374502 | lifeskim:mentions | umls-concept:C0080103 | lld:lifeskim |
pubmed-article:8374502 | lifeskim:mentions | umls-concept:C0227525 | lld:lifeskim |
pubmed-article:8374502 | lifeskim:mentions | umls-concept:C0007603 | lld:lifeskim |
pubmed-article:8374502 | lifeskim:mentions | umls-concept:C0031603 | lld:lifeskim |
pubmed-article:8374502 | lifeskim:mentions | umls-concept:C1882726 | lld:lifeskim |
pubmed-article:8374502 | lifeskim:mentions | umls-concept:C0002059 | lld:lifeskim |
pubmed-article:8374502 | lifeskim:mentions | umls-concept:C0021467 | lld:lifeskim |
pubmed-article:8374502 | lifeskim:mentions | umls-concept:C0021469 | lld:lifeskim |
pubmed-article:8374502 | lifeskim:mentions | umls-concept:C0243144 | lld:lifeskim |
pubmed-article:8374502 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:8374502 | pubmed:dateCreated | 1993-10-19 | lld:pubmed |
pubmed-article:8374502 | pubmed:abstractText | Rat liver plasma membrane alkaline phosphatase (ALP) phospho-intermediates, which have molecular masses of 151 and 135 kDa bands, were labelled at physiological pH with either (gamma-32P) ATP or 32Pi. This labeling was stabilized by a potent enzyme inhibitor, bromolevamisole (BL), and not by bromodexamisole (BD). BL augmented the rate and extent of autophosphorylation and slowed down the rate of autodephosphorylation of ALP. The phospho-intermediates labeling presented nearly the same kinetic behaviour with either (gamma-32P) ATP or 32Pi. In the presence of BL a marked decrease of the phosphorylation state of many proteins was observed in hepatocytes. BL also produced a decrease of the 32Pi uptake into hepatocytes and a decrease of the specific radioactivity of cellular ATP. BD had nearly the same effect as BL on protein phosphorylation and 32Pi uptake. These results argued against a direct involvement of ALP in Pi transport across hepatocyte plasma membrane. | lld:pubmed |
pubmed-article:8374502 | pubmed:language | eng | lld:pubmed |
pubmed-article:8374502 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8374502 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:8374502 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8374502 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8374502 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8374502 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8374502 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8374502 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8374502 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8374502 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8374502 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:8374502 | pubmed:month | Jul | lld:pubmed |
pubmed-article:8374502 | pubmed:issn | 0145-5680 | lld:pubmed |
pubmed-article:8374502 | pubmed:author | pubmed-author:BaudryMM | lld:pubmed |
pubmed-article:8374502 | pubmed:author | pubmed-author:RiverEE | lld:pubmed |
pubmed-article:8374502 | pubmed:author | pubmed-author:LalégeriePP | lld:pubmed |
pubmed-article:8374502 | pubmed:author | pubmed-author:SarrouilheDD | lld:pubmed |
pubmed-article:8374502 | pubmed:author | pubmed-author:MétayéTT | lld:pubmed |
pubmed-article:8374502 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:8374502 | pubmed:volume | 39 | lld:pubmed |
pubmed-article:8374502 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:8374502 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:8374502 | pubmed:pagination | 469-77 | lld:pubmed |
pubmed-article:8374502 | pubmed:dateRevised | 2003-11-14 | lld:pubmed |
pubmed-article:8374502 | pubmed:meshHeading | pubmed-meshheading:8374502-... | lld:pubmed |
pubmed-article:8374502 | pubmed:meshHeading | pubmed-meshheading:8374502-... | lld:pubmed |
pubmed-article:8374502 | pubmed:meshHeading | pubmed-meshheading:8374502-... | lld:pubmed |
pubmed-article:8374502 | pubmed:meshHeading | pubmed-meshheading:8374502-... | lld:pubmed |
pubmed-article:8374502 | pubmed:meshHeading | pubmed-meshheading:8374502-... | lld:pubmed |
pubmed-article:8374502 | pubmed:meshHeading | pubmed-meshheading:8374502-... | lld:pubmed |
pubmed-article:8374502 | pubmed:meshHeading | pubmed-meshheading:8374502-... | lld:pubmed |
pubmed-article:8374502 | pubmed:meshHeading | pubmed-meshheading:8374502-... | lld:pubmed |
pubmed-article:8374502 | pubmed:meshHeading | pubmed-meshheading:8374502-... | lld:pubmed |
pubmed-article:8374502 | pubmed:meshHeading | pubmed-meshheading:8374502-... | lld:pubmed |
pubmed-article:8374502 | pubmed:meshHeading | pubmed-meshheading:8374502-... | lld:pubmed |
pubmed-article:8374502 | pubmed:meshHeading | pubmed-meshheading:8374502-... | lld:pubmed |
pubmed-article:8374502 | pubmed:meshHeading | pubmed-meshheading:8374502-... | lld:pubmed |
pubmed-article:8374502 | pubmed:meshHeading | pubmed-meshheading:8374502-... | lld:pubmed |
pubmed-article:8374502 | pubmed:meshHeading | pubmed-meshheading:8374502-... | lld:pubmed |
pubmed-article:8374502 | pubmed:meshHeading | pubmed-meshheading:8374502-... | lld:pubmed |
pubmed-article:8374502 | pubmed:meshHeading | pubmed-meshheading:8374502-... | lld:pubmed |
pubmed-article:8374502 | pubmed:meshHeading | pubmed-meshheading:8374502-... | lld:pubmed |
pubmed-article:8374502 | pubmed:year | 1993 | lld:pubmed |
pubmed-article:8374502 | pubmed:articleTitle | Stabilization of phospho-intermediates of rat liver plasma membrane alkaline phosphatase by uncompetitive inhibition. Relation with phosphate uptake into hepatocytes. | lld:pubmed |
pubmed-article:8374502 | pubmed:affiliation | Groupe de Recherche et d'Etude d' Analogues de Médicaments, Faculté de Médecine et de Pharmacie, Poitiers, France. | lld:pubmed |
pubmed-article:8374502 | pubmed:publicationType | Journal Article | lld:pubmed |